Core Viewpoint - Jiangsu Nanfang Weicai Pharmaceutical Co., Ltd. (Nanfang Weicai) has announced that its wholly-owned subsidiary, Anhui Nanfang Medical Products Co., Ltd., will provide a maximum joint liability guarantee of RMB 65 million for financing activities with Jiangsu Bank [1][2]. Summary by Sections Guarantee Overview - The guarantee amount provided by Anhui Nanfang is RMB 65 million, which includes the principal, interest, and all related debts [1][2]. - The company has approved a comprehensive financing credit limit of up to RMB 1 billion, which can be used for various financial instruments including loans and bank guarantees [1][2]. Internal Decision-Making Process - The guarantee was approved in the 18th meeting of the fourth board of directors and the 2024 annual general meeting [1][5]. - The financing activities and guarantees do not require separate approval from the shareholders' meeting [2][5]. Financial Status of the Guaranteed Party - Nanfang Weicai's total assets are approximately RMB 103.83 million, with total liabilities of about RMB 76.11 million, resulting in a net asset of around RMB 27.14 million [3]. - The company reported a revenue of RMB 17.09 million and a net loss of RMB 791.79 thousand in the last fiscal year [3]. Guarantee Necessity and Reasonableness - The guarantee is deemed necessary and reasonable to support the company's operational funding needs, with a stable business condition and good credit status [4][5]. - The guarantee is structured to be fair and compliant with relevant policies and regulations [4][5]. Total External Guarantee Situation - As of the announcement date, the total external guarantee balance of the company and its subsidiaries is RMB 349.61 million, exceeding the latest audited net assets by 125.18% [5][6]. - There are no overdue guarantees reported by the company [6].